KRAS G12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemia

Leukemia. 2024 Jul;38(7):1609-1612. doi: 10.1038/s41375-024-02244-4. Epub 2024 Apr 18.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Female
  • Gene Rearrangement*
  • Histone-Lysine N-Methyltransferase* / genetics
  • Humans
  • Leukemia, Myeloid, Acute* / genetics
  • Male
  • Middle Aged
  • Mutation*
  • Myeloid-Lymphoid Leukemia Protein* / genetics
  • Prognosis
  • Proto-Oncogene Proteins p21(ras)* / genetics
  • Young Adult

Substances

  • Myeloid-Lymphoid Leukemia Protein
  • KMT2A protein, human
  • Histone-Lysine N-Methyltransferase
  • Proto-Oncogene Proteins p21(ras)
  • KRAS protein, human